Role of Phosphorylation in the Control of Clathrin-Mediated Internalization of GPCR by Delom, Frederic & Fessart, Delphine
Hindawi Publishing Corporation
International Journal of Cell Biology






1Bordeaux Cardiothoracic Research Center, Bordeaux University, 146, L´ eo-Saignat, 33076 Bordeaux, France
2Inserm U1045, 146, L´ eo-Saignat, 33076 Bordeaux, France
Correspondence should be addressed to Delphine Fessart, delphine.fessart@yahoo.fr
Received 28 January 2011; Accepted 1 April 2011
Academic Editor: Michael Hortsch
Copyright © 2011 F. Delom and D. Fessart. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
The process by which G protein-coupled receptors (GPCRs) are internalized through the clathrin-coated vesicles involves inter-
actions of multifunctional adaptor proteins. These interactions are tightly controlled by phosphorylation and dephosphorylation
mechanisms resulting in the regulation of receptor endocytosis. However, the identities of the kinases involved in this process
remained largely unknown until recently. This paper discusses advances in our knowledge of the important role played by protein
phosphorylation in the regulation of the endocytic machinery and how phosphorylation controls the coated vesicle cycle.
1.AnOverviewonGProtein-CoupledReceptors
(GPCRs)Internalization
Reversible protein phosphorylation by the interplay between
kinases and phosphatases is a major regulatory mechanism
for G protein-coupled receptors (GPCRs) internalization
[1–3]. Therefore, the aim of this paper is to synthesise
our understanding of the phosphorylation mechanisms
regulating GPCRs internalization. Growing interest in this
ﬁeld is due to the involvement of GPCRs in the regulation
of a number of functions. Following their activation, these
receptors enter inside the cells, a process named receptor
internalization. This process requires receptor desensitiza-
tion which is achieved by receptor phosphorylation, seques-
tration and internalization. In this manner, receptors are
removed from the surface and transferred into cells. Inside
the cells, receptors are embedded into small membrane
vesicles (endosomes) which may be recycled back to the
plasma membrane in order to renew their fully functional
coupling with proteins and eﬀectors (i.e., resensitization).
GPCRs expression can also be regulated by a process of
downregulation which is a terminal stage of receptor life
where receptors are degraded in lysosomes. However, it is
now becoming apparent that GPCRs can also be regulated
independently of their phosphorylation state (reviewed in
[4]). Before starting the role played by phosphorylation
duringreceptorinternalization,a briefreview ofthediﬀerent
steps controlling receptor internalization will be given.
1.1.StepsConductingtoReceptorInternalization. Thecurrent
proposed model for GPCRs internalization is essentially
based on β2-adrenergic receptor (β2-AR) studies. Brieﬂy,
following agonist stimulation, GPCRs undergo conforma-
tional change that allow binding of G proteins, leading to
the activation of diﬀerent eﬀectors and signaling pathways
[5]. The desensitization process is then activated (Figure 1).
One of the ﬁrst steps involves the functional “uncoupling”
of the G proteins from the receptors. The receptor is
subsequently phosphorylated by G protein-coupled receptor
kinases (GRKs) to enhance the binding of β-arrestins (step
1, Figure 1). β-arrestins act as scaﬀolding intermediates with
components of the clathrin-coated-pit machinery, thus sta-
bilizing association with clathrin-coated pits (CCPs) (steps
2a n d3 ,Figure 1). The formed pits progressively invaginate
and are ﬁnally released into the cytosol as a free clathrin-
coated vesicle (CCV) (step 4, Figure 1), a step which requires
the GTPase activity of dynamin to pinch oﬀ clathrin-
coated vesicles from the plasma membrane [6]. After coat













































Figure 1: Steps conducting to G protein coupled receptors internalization. Internalization and recycling of GPCRs. Upon agonist binding,
receptors are phosphorylated (P) by GRKs leading to the recruitment of β-arrestins (step 1). Beta-arrestins, through their interaction with
clathrin and AP-2, target the receptor/arrestin complexes to clathrin coated pits (step 2). Beta-arrestins also bind c-Src (steps 2 and 3).
Dynamin (step 3), a GTPase, regulates the pinching oﬀ from the cell surface of clathrin-coated pits (steps 3 and 4). Once clathrin-coated
vesicles are formed (step 4), the receptor is then internalized into endosomes (step 5), dephosphorylated before returning to the cell surface
(step 6), or the receptor is degradated to lysosomes (step 7).
must be disassembled so that the CCV can fuse with an
early endosome (step 5, Figure 1). The early endosome
controls the activity and the destination of proteins in the
compartment. Therefore, endosomes are a key control point
for sorting receptors, which can be directed to recycling
endosomes and back to the cell surface (step 6, Figure 1),
or directed to late endosomes or lysosomes for degradation
(step 7, Figure 1). Even though several groups have studied
GPCRs internalization via the clathrin-coated vesicles, a
clear picture of all the phosphorylated proteins involved in




Following receptor activation by an agonist, the receptor
undertakes the process of desensitization, deﬁned as “oﬀ
switch” of all receptor functions triggered by the agonist at
the plasma membrane. Therefore, GPCRs control their own
responsiveness to dampen the physiological response to the
continued presence of the stimulus [7] .T h i sp r o c e s si st h e
consequence of a combination of diﬀerent mechanisms. The
cloning of the β2-AR in 1986 and its shared homology with
the rhodopsin receptor [8] allowed the discovery that both
receptors become phosphorylated in a stimulus-dependent
way and that this phosphorylation seemed to be related
to the process of receptor desensitization. Desensitization
is thought to be mediated through phosphorylation of
serine and threonine residues by G protein-coupled receptor
kinases (GRKs) [9], second messenger-dependent protein
kinases such as cAMP-dependent kinase (PKA), and protein
kinase C (PKC) [10–14].
2.1. ReceptorPhosphorylationby SecondMessengers: Heterolo-
gous Desensitization. PKA and PKC are phosphotransferases
that catalyze the transfer of the γ-phosphate group of ATP
to serine and threonine residues contained within speciﬁc
amino acid consensus sequences of proteins. They can
phosphorylate a receptor even in the absence of its agonist,
resulting in “heterologous” desensitization (reviewed in
[15]). These kinases are activated in response to GPCRs-
stimulated increases in intracellular second messengers, such
as cAMP, Ca2+ and diacylglycerol (DAG), and participate in
GPCRs signaling by mediating the phosphorylation of the
receptor itself or other downstream target proteins. In the
latter case, receptors that have not been activated by a ligand
maybecomedesensitizedbyactivationofthesekinases.PKA-
mediated receptor phosphorylation has also been shown, in
the case of the β2-AR, to switch coupling of the receptor
away from Gs in favour of enhanced coupling to Gi [16].
Several other receptors, including the prostacyclin receptor,
also seem to undergo such PKA-mediated switching in their
G protein-coupling speciﬁcity [17]. The phosphorylationInternational Journal of Cell Biology 3
of GPCRs by PKA and PKC has also been shown for
other receptors such as gamma-aminobutyric acid receptor
type B (GABAB)[ 18, 19]. In addition to these kinases,
the 5
 AMP-dependent kinase (AMPK), a serine/threonine
protein kinase, has been shown to phosphorylate GABAB
receptor on Ser-783 to further decrease receptor desensiti-
sation [20].
2.2. Receptor Phosphorylation by G Protein-Coupled Receptor
Kinases (GRKs): Homologous Desensitization. By the mid-
1980s, it had become clear that both rhodopsin [21]a n dt h e
β2-AR [22] were phosphorylated in a stimulus-dependent
way, and that this phosphorylation seemed to be related
to receptor inactivation or desensitization. In the case of
rhodopsin, the enzyme responsible for the phosphorylation
was referred to as rhodopsin kinase [23] .I nt h ec a s eo f
the β2 - A R ,an o v e lc A M P - i n d e p e n d e n tk i n a s e[ c a l l e dt h eβ-
adrenergic receptor kinase (βARK)] appeared to contribute
to agonist-dependent phosphorylation of the receptor [24].
Now, 7TM receptors (GPCRs) are traditionally thought to
signal by means of activation of heterotrimeric G proteins
and then to be desensitized by GRKs which are recruited
to and speciﬁcally phosphorylate only agonist-occupied
receptors leading to “homologous desensitization” [24, 25].
2.2.1. GRK Family. GRKs phosphorylate GPCRs at both
serineandthreonineresidueslocalizedwithinthethirdintra-
cellular loop (i3) or C-terminal tail domain [26]. Although
no putative GRK phosphorylation consensus motifs have
beenidentiﬁed,localizationofaminoacidicresiduesﬂanking
repeated serines/threonines to the site of phosphorylation
seems to favour GRK-2-mediated phosphorylation [27]. So
far, only GRKs selectively phosphorylate agonist-activated
receptors, whereas second messenger-dependent kinases can
phosphorylate receptors in the presence or absence of an
agonist. Seven mammalian GRK genes have been identiﬁed,
some of which undergo alternative splicing to generate
diﬀerent isoforms [26, 28]. The GRKs consist of three
distinct domains: the kinase domain, the N-terminal RGS
(regulator of G protein signaling) domain, and the C-
terminaldomainwhich contributestotheplasma membrane
targeting of the kinase. The function of RGS proteins is to
inhibit the activity of the Gα-subunit by acting as GTPase-
activating proteins (GAPs) [29]. The speciﬁcity of GRKs
in vitro has not yet been deﬁned, but tissue distribution,
as well as levels of expression, probably contributes to
their speciﬁcity in vivo [30–32]. However, studies show that
diﬀerent GRKs induce distinct signaling upon Angiotensin
II type 1 receptor (AT1R) or V2 vasopressin receptor (V2R)
activation,andsuggestthatGRK-2and-3will antagonizethe
eﬀects of GRK-5 and -6 [33, 34]. Several factors control the
activity of the kinases towards the receptors. Principally, the
activated conformations of the receptors themselves activate
the enzymes [31].
2.2.2. GRK Phosphorylation to Regulate its Own Activity. A
regulatory complexity is added by the fact that GRK activity
can be inﬂuenced by phosphorylation. Mitogen-activated
protein kinase (MAPK) decreases its eﬃcacy towards GPCRs
substrates [35], whereas both PKA and PKC can phospho-
rylate and activate GRK-2 by promoting its Gβγ-mediated
membrane association [36, 37] and potentiating its activity
[36, 38]. In contrast, GRK-5 activity can be inﬂuenced by
phosphorylation of PKC kinase to reduce its activity [39].
Moreover,c-Src,viaitsrecruitmenttotheagonist-dependent
binding of β-arrestin to GPCRs, phosphorylates GRK-2 on
tyrosine residuesandtargetsGRK-2fordegradation[40,41].
2.2.3. GRK Phosphorylation of Receptors for β-Arrestin
Recruitment. GRK-phosphorylation of receptors is not suf-
ﬁcient for desensitization, but rather serves to create high
aﬃnity sites to promote the recruitment of the cytoplasmic
accessory proteins, arrestins, and target the receptors for
internalization via clathrin-coated pits. The arrestin protein
was ﬁrst identiﬁed by Wilden et al. in 1986 as, “a 48K
protein”, bound to the phosphorylated rhodopsin, thereby
interfering with its coupling to transducin [42]. The protein
was later renamed arrestin [43]. Therefore, it was postulated
that the GRK-mediated phosphorylation of clusters of serine
and threonine residues in the C-terminal tails of some
receptors may regulate the stability of receptor/arrestin
complexes [44]. For most receptors, the determining factor
for β-arrestin interaction is the phosphorylation status
of the activated GPCRs. Thus, impairment of receptor
phosphorylation by mutagenesis of key serine/threonine
residues generally leads to diminished β-arrestin binding
after stimulation of the M2 muscarinic cholinergic receptor,
rhodopsin, the AT1R, or the V2R [45–48]. The arrestins
recruitment in turn induces desensitization by preventing
further coupling to G proteins [49, 50]. However, there
are some exceptions and widespread variations against a
general model of receptor phosphorylation in the regulation
of internalization. For example, the ﬁndings that mutants of
the parathyroid hormone receptorunderwent endocytosisin
the absence of detectable agonist-induced phosphorylation
[51]. In addition, Richardson et al., [52]h a v es h o w nt h a t
substance P receptor lacking the C-terminal domain remains
competent to desensitize and internalize. These and similar
data obtained with a truncated opioid receptor [53]o rw i t h
the leukotriene B4 receptor 1 (BLT1) [54] do not support a
general role for receptor phosphorylation in the control of
GPCRs internalization. Overall, these ﬁndings led Kim et al.
to suggest that the role of receptor phosphorylation allow
the access of arrestin to its receptor binding domain than to
create an arrestin-binding site [55].
2.3. Receptor Phosphorylation by Casein Kinase II (CK2).
Casein kinase II has been reported to phosphorylate the
M3–muscarinic receptor in cerebella granule neurons and to
aﬀect coupling to the Jun-kinase pathway [56]. It was also
suggested that 3 putative CK2 phosphorylation sites on the
carboxyltailoftheTSH-releasinghormonereceptor(TRHR)
were important for its internalization [57]. In addition to
TRHR receptor, the Leukotriene B4 receptor (Gαo-coupled)
contains also a putative CK2 site, which, when mutated,
reducedGRK-6-mediated desensitization[58].Rebholzet al.4 International Journal of Cell Biology
have suggested that GPCRs regulation by CK2 is exerted
through its ability to enable faster endocytosis of Gs-coupled
receptors [59]. However, it remains unclear if this type




Despite numerous studies suggesting an essential role of
arrestins in GPCRs regulation, the detailed mechanism un-
derlying the function of arrestins and receptor-mediated
modulation of arrestin activity is unclear. β-Arrestin are
component of a multiprotein complex that assembles on
the receptor after ligand stimulation. Acting as a protein
scaﬀold, it recruits Src kinase and also binds to clathrin,
and adaptor-protein 2 (AP-2), which serves to target the
activated GPCRs to clathrin-coated pits for internalization.
β-Arrestin also induce rapid homologous desensitization
of the receptor by binding to the GPCRs and sterically
inhibiting further G-protein coupling. However, several
reports on arrestin phosphorylation provide some insight
into potential regulation of arrestin function.
3.1. Arrestin Phosphorylation by Extracellular Signal-Regu-
l a t e dK i n a s e s1a n d2( E R K 1 / 2 ) .Studies on mammalian β-
arrestin 1 demonstrate that β-arrestin 1 was constitutively
phosphorylated at Ser-412 by extracellular signal-regulated
kinases 1 and 2 and became dephosphorylated following
β2AR stimulation [60, 61]. β-arrestin 1 phosphorylation was
proposed to regulate the interaction of arrestin with clathrin
and Src, since a S412D mutant mimicking phosphorylated
β-arrestin 1 had reduced binding to these proteins [60,
62]. Thus, agonist treatment of GPCRs, which induces
dephosphorylation of β-arrestin 1 at Ser-412, as well as
transfection ofthe S412A β-arrestin 1 mutant, which mimics
dephosphorylated β-arrestin 1 and enhances clathrin and
Src binding to β-arrestin 1, resulting in enhanced GPCRs
internalization. Notably, β-arrestin 2 shares ∼80% amino
acid identity with β-arrestin 1 but does not contain the
corresponding serine residue. Thus, β-arrestin 2 might be
phosphorylated at other sites or perhaps be regulated by
diﬀerent mechanisms.
3.2. Arrestin Phosphorylation by GRK. Recently, β-arrestin
1 has also been shown to be phosphorylated at Ser-412 by
GRK-5 [63]. This phosphorylation, in turn, prevents the
activation of c-Src and, therefore, blocks ERK signalling.
3.3. Arrestin Phosphorylation by CK2. Kim et al. have re-
ported that β-arrestin 2 is constitutively phosphorylated by
casein kinase II at Thr-383 and suggested that β-arrestin
2 phosphorylation may regulate its interaction with novel
binding partners unidentiﬁed [64]. Threonine 383 is the
primary phosphorylation site, and serine 361 represents a
secondary site [64, 65]. Dephosphorylation of β-arrestins at
the plasma membrane seems to be necessary for engaging
endocytic partners.
3.4. Arrestin Phosphorylation by Calcium/Calmodulin-De-
pendent Kinase II (CaMKII). In Drosophila, t w ov i s u a ls y s -
tem arrestins have been identiﬁed: Arr1 and Arr2. Both Arr1
and Arr2 are phosphorylated in a light-dependent manner,
and it has been established that Arr2 is phosphorylated by a
Ca2+/calmodulin-dependent protein kinase (CaMKII) [66].
Although it has been known for quite some time that Arr2
is phosphorylated in a light-dependent manner, it is unclear
just what role this phosphorylation serves. Studies with
Drosophila visual arrestin-2 demonstrate that it undergoes
light-dependent phosphorylation by calcium/calmodulin-
dependent kinase II and that phosphorylation is necessary
for dissociation of arrestin from rhodopsin [67, 68]. It
has been proposed that the calcium- and light-dependent
phosphorylation of Arr2 acts as the signal to bind and
inactivate metarhodopsin, and therefore, Arr2 phosphory-
lation serves to modulate the inactivation of the signaling
cascade [66, 69–71]. However, recent evidence suggest that
the phosphorylation of Arr2 is also necessary for its release
from membranes once rhodopsin has been photoconverted
back to its inactive form [68].
3.5. Arrestin Phosphorylation by Src. Src kinases phosphory-
lates tyrosine residues on the clathrin coated pit structural
proteins including clathrin itself and dynamin but also β-
arrestin. There are four tyrosines present in the N-terminall
part of β-arrestin-1 that are not conserved in β-arrestin-2
[72].OneoftheseresiduesisTyr-54 which isphosphorylated
by Src, and a single point mutation Y54F is suﬃcient to
prevent its phosphorylation. The constitutive substitution of
β-arrestin-1 tyrosine 54 by phenylalanine increases the β-
arrestin-1 interaction with the μ-subunit of the AP-2 and
enhances β-arrestin-1-mediated β2-AR internalization.
Furthemore, β-arrestin has been shown recently to
mediate phosphorylation events by activating 38 protein
kinases [73]. However, it remains unclear if this eﬀect is
correlated with the β-arrestin-phosphorylation status.
4.RegulationofGPCRsInternalizationby
ClathrinPhosphorylation
Clathrin is also subject to phosphorylation both in vitro
and in vivo and are thought to serve as regulatory subunits
[74, 75]. The very limited data on this suggest that the
phosphorylation of clathrin could be inhibitory for coat
assembly [76, 77].
4.1. Clathrin Phosphorylation by c-Src. Tyrosine phosphory-
lation of clathrin was shown only for the epidermal growth
factor receptor. Tyrosine phosphorylation of the clathrin
heavy chain by Src-family kinases enhances the clathrin
recruitment to the plasma membrane. It was shown that
ligand binding to the epidermal growth factor receptor
leads, via activation of protein kinase activity, to clathrin
phosphorylation [78].
4.2. Clathrin Phosphorylation by CK2. Casein kinase 2 plays
an essential role in endocytosis, the inhibition of CK2 leadsInternational Journal of Cell Biology 5
to a signiﬁcant decrease in transferrin uptake [79]. CK2 is
highlyenriched in CCVpreparations andphosphorylates the
clathrin light chain in vitro [75]. As mentioned above, the
clathrin light chain is also found to be phosphorylated in
vivo, but the functional role of this phosphorylation event
in endocytosis is not entirely clear.
5.RegulationofGPCRsInternalizationby
AdaptorProteins(AP)
Clathrin-mediated endocytosis is the well-described mech-
anism for the entry of molecules into cells. This pathway
is characterized by the recruitment of soluble clathrin from
the cytoplasm to the plasma membrane. Clathrin-binding
adaptors, such as the adaptor-protein 2 (AP-2), are the key
components of this pathway. They bind directly to clathrin
[80],aswellasβ-arrestin andotherendocyticregulatorypro-
teins to stimulate the formation of the clathrin coat [81]. In
thismodel,theclathrinadaptorcomplexAP-2playsacentral
role in CCP formation and function, being responsible for
the assembly of clathrin triskelia at the plasma membrane
and selection of cargo receptors that will be internalized
by forming CCVs. AP-2 is a heterotetramer composed of
two large subunits (α-adaptin and β2-adaptin), a medium
subunit (μ2), and a small subunit (σ2). It has been known
for some time that several proteins associated with clathrin-
coated vesicles are substrates for protein kinases. These
proteins include AP-2, dynamin, clathrin, synaptojanin 1,
and amphiphysins. However, the identities of the kinases
involved in this process remained largely unknown until
recently. So far, only three of the four adaptor complex
subunits of AP-2 have been shown to be phosphorylated.
5.1. Serine/Threonine Phosphorylation of the μ2-Subunit of
AP-2 by Cyclin G-Associated Protein Kinase (GAK). It has
been known for many years that μ2 is phosphorylated
both in vivo,a n din vitro but the functional relevance
of these posttranslational modiﬁcations was unclear [82].
The identity of the kinase that phosphorylates μ2r e m a i n e d
obscure for a long time. Two candidate kinases have been
described in the literature [83–88]. One of them, termed
GAK (for cyclin G-associated protein kinase), was shown
to phosphorylate μ2 recombinant proteins in vitro [86].
It was also demonstrated that GAK copuriﬁes with CCVs,
and that immunoprecipitated GAK can phosphorylate the
endogenous μ2 subunit in vitro [85]. GAK is a complex
protein; in addition to an N-terminal kinase domain, it
containsacentraltensin homologydomainand aC-terminal
J domain. This C-terminal domain shows similarity to
auxilin, a neuronal protein that facilitates Hsc70 in the
uncoatingofCCVs.Hence,analternative(andpossiblymore
appropriate) name for GAK is auxilin 2 [87]. GAK was
shown to bind directly to both clathrin and the appendage
domain of α-adaptin [86]. GAK/auxilin 2 is localized mostly
to the trans-Golgi network (in HeLa cells at least). However,
its overexpression completely prevents transferrin uptake
[86,87,89]implyinga roleforGAK/auxilin2in endocytosis.
Given the multifunctional nature of GAK/auxilin 2, it
is presently diﬃcult to conclude whether the eﬀect of
GAK/auxilin 2 overexpression on endocytosis is due to its
role in clathrin uncoating or μ2 phosphorylation.
5.2. Serine/Threonine Phosphorylation of the μ2-Subunit
of AP-2 by α-Adaptin-Associated Kinase-1 (AAK1). It was
shown, in vitro,t h a tμ2 phosphorylation is required for
internalization of Transferrin receptor [90]. However, with
the identiﬁcation of Thr-156 as a residue essential for
clathrin-coatedpitfunctionin vivo[83,84],itappearsclearly
that phosphorylation play an important role in endocytosis.
Several studies indicate that the phosphorylation of Thr-
156 on μ2-subunit induced by α-adaptin-associated kinase-
1 (AAK1), could regulate its binding to endocytic cargo
[83, 84, 91]. AAK1 was identiﬁed using a phage display
libraryscreeningstrategy[84].JustlikeGAK/auxilin2,AAK1
isenrichedinpuriﬁedCCVpreparationsandphosphorylates
the μ2 subunit of AP-2 in vitro [84]. Although some
observations havedemonstratedthattheμ2phosphorylation
is not obligatory for receptor uptake, it is critical for
maximizing internalization eﬃciency [90, 92]. Additionally,
serine/threonine phosphorylation of AP-2 in the hinge
region, between the C-terminal ear and the N-terminal
domains of the beta-subunit, has been shown to aﬀect AP-
2’s ability to interact with clathrin and to associate with
membranes [74]. Thus, phosphorylation of AP-2 complexes
regulates their recruitment to the plasma membrane [93],
their interaction with cargo molecules containing tyrosine-
sortingsignals[83],andtheirassemblywithclathrin[74,94].
5.3.Phosphorylation of α-a n dβ2-Subunits ofAP-2 byCK2. It
was found thatCasein kinase 2 (CK2)phosphorylates theα−
and β2-subunits of the AP-2 adaptor complex in vitro [85].
It is possible that CK2 plays the same role in vivo. In vitro
phosphorylationofAP-2byCK2preventsAP-2frombinding
to clathrin cages, thus mimicking the eﬀect observed in vivo
[74].
5.4. Tyrosine Phosphorylation of β2-Subunit of AP-2 by Src.
The list of GPCRs-activated signaling pathways in which β-
arrestins havebeenimplicatedincludesnotonlycomponents
of the clathrin-endocytic machinery, but also signaling
moleculessuchasthenon-receptortyrosinekinaseSrcfamily
[95–101]. Src family kinases exhibit a highly conserved
structural organization that includes a myristoylated N-
terminal domain to facilitate its attachment at the plasma
membrane, followed by the SH3 domain recognizing a
proline-rich region, the SH2 domain recognizing tyrosine
phosphorylated residues, the tyrosine kinase domain (SH1)
and a C-terminal tail [102]. Thus, targeting of Src family
kinase is accomplished through protein-protein interac-
tions involving the phosphotyrosine-binding Src homology
domain 2 (SH2) and proline-rich domain-binding SH3
domains common to all members of the family. Today, c-Src
is described as an important regulator of GPCRs endocytosis
based on MEF cells deﬁcient of Src-family tyrosine kinases
(SYF cells), where the internalization of β2AR was abolished
[103].Uponstimulationoftheβ2AR,c-Srcrapidlyassociates6 International Journal of Cell Biology
with the receptor in a β-arrestin-dependent manner [62].
c-Src mutants devoid of catalytic activity that can interact
with β-arrestin (SH1-KD) function as dominant-negative
inhibitors of clathrin-mediated internalization of receptors
[100, 104]. Also, several new substrates for the c-Src phos-
phorylation of proteins involved in the endocytic machinery
have been identiﬁed (see Table 1).
It has been suggested that c-Src recruitment to the
endocytic complexes may play a role in the activation of
the endocytic machinery [78, 100, 101]. This has been
conﬁrmed by Fessart et al. that the recruitment of Src to
the β-arrestin/AP-2 complex is necessary for the agonist-
dependent phosphorylation of the β2-subunit on Tyr-737,
and regulates the disassembly of the endocytic complex
and AT1R internalization [105]. This mechanism has been
demonstrated for other GPCRs like the β2-adrenergic, vaso-
pressin V2, bradykinin type 2, platelet-activating factor, and
endothelin A receptors but also for other type of receptors
such as epidermal growth factor receptor [106].
6.RegulationofGPCRsInternalizationby
Dynamin Phosphorylation
During receptor internalization, it was initially thought
that β-arrestin participated in the de novo formation of
CCPs [107, 108]. However, recent evidence shows that β-
arrestin targets receptors to existing pits at the cell surface
and engage them in the internalization process [109, 110].
Although this issue remains controversial, the general model
for receptor internalization from the plasma membrane is
that the formed pits progressively invaginate and are ﬁnally
released into the cytosol as free CCV, a step which requires
the activity of dynamin. Dynamin is a GTPase involved in
the pinching oﬀ of clathrin-coated vesicles from the plasma
membrane [6].
6.1. Dynamin Phosphorylation by c-Src. Dynamin is regu-
lated by tyrosine phosphorylation during β2-AR internaliza-
tion. The proposed model is that β-arrestin will act as an
adaptor/scaﬀold to bind c-Src, allowing the phosphorylation
of dynamin [100]. Ahn and collaborators identiﬁed two
tyrosines (Y231F/Y597F) in dynamin that, when mutated,
cannot be tyrosine phosphorylated by c-Src, and thus inhibit
the agonist-induced internalization of the β2-AR. These
data were also conﬁrmed for the M1 muscarinic receptor
[111], suggesting that tyrosine phosphorylation of dynamin
plays an important role in endocytosis. Recently, Src kinase
activity has been shown to regulate the endocytosis of the
transferrin by phosphorylating two important components
of the endocytic machinery, namely, the large GTPase
dynamin 2 (Dyn2) and its associated actin-binding protein,
cortactin (Cort) [112]. Src phosphorylation of dynamin
seems also to act to increase both dynamin self-assembly and
GTPase activity [113].
6.2. Dynamin Phosphorylation by Protein Kinase C (PKC).
DynaminIisalsophosphorylatedbyproteinkinaseCinvitro
and probably by PKC in intact nerve terminals [114–117].
Dynamin I is then dephosphorylated by the Ca2+-dependent
phosphatasecalcineurininvitro andinnerveterminals[118–
121]. After dephosphorylation, dynamin I is fully rephos-
phorylated within 2 min [114, 122]. Rephosphorylation can
be inhibited with a range of low-speciﬁcity PKC antagonists,
suggesting that PKC is the dynamin I kinase in nerve termi-
nals [114]. This PKC-mediated phosphorylation of dynamin
has been proposed as a mechanism to remove dynamin I
from the plasma membrane to a cytosolic compartment,
where it is appropriately localized to participate in the next
cycle of endocytosis [123].
6.3. Dynamin Phosphorylation by Cyclin-Dependent Kinase
5( C d k 5 ) .Although several kinases for dynamin have been
reported based on in vitro studies, Cdk5 has recently been
reported to phosphorylate dynamin both in vivo and in vitro,
and the phosphorylation sites have been determined. Cdk5
is one of the proline-directed kinases and phosphorylates
serine/threonine motifs [124]. Cdk5 phosphorylates Thr-
780 in dynamin 1 [125]. The phosphorylation of dynamin
reduces its ability to interact with the amphiphysin 1.
7.RegulationofGPCRsInternalizationby
Synaptojanin 1Phosphorylation
Synaptojanin 1 is a presynaptic inositol 5-phophatase enri-
ched on endocytic intermediates [126]. As mentioned previ-
ously,synaptojanin isalsofoundtobephosphorylatedinvivo
[127], but the functional role of this phosphorylation event
in endocytosis remains to be determined.
8.RegulationofGPCRsInternalizationby
Amphiphysin Phosphorylation
Amphiphysin dimer binds both dynamin and Synaptojanin
1[ 128–130]. Disruption of these interaction blocks clathrin-
mediated endocytosis at the step of invaginated coated
pits [131]. The amphiphysin also binds to clathrin and
to the α-subunit of AP-2 [131, 132]. The phosphorylation
of amphiphysin aﬀects its binding to AP-2. Thus, this
complex formation is inhibited by phosphorylation [127].
At least 3 protein kinases have been shown to phosphorylate
amphiphysin I: Cdk5, MAPK/ERK and CK2.
8.1. Amphiphysin Phosphorylation by Cyclin-Dependent
Kinase 5 (Cdk5). Cdk5 has recently been reported also to
phosphorylate amphiphysin 1 in vivo and in vitro,a n dt h e
phosphorylation sites have been determined. Cdk5 phos-
phorylates Ser- residues 261, 272, 276, and 285 and Thr-
310 in amphiphysin 1 [125]. The phosphorylation at
these sites is important for regulating the interactions of
amphiphysin I with its endocytic partners, clathrin, AP-
2, endophilin and lipid membrane. Cdk5 has multiple
functions in neurons, implicated in the regulation of a
range of cellular processes from adhesion and motility to
synaptic plasticity and drug addiction [124, 133]. Cdk5 is
abundant in presynaptic terminals in mature neurons [134].
The simultaneous phosphorylation of both amphiphysin IInternational Journal of Cell Biology 7
Table 1: Functional role of phosphorylation by Protein Kinase(s) in vitro and in vivo during clathrin-mediated internalization.
Phosphorylation substrates Kinase Possible roles References
Dynamin [Tyr-231 Tyr-597] Src [100]
Dynamin PKC stimulates GTPase activity [115]
Dynamin [Thr-780] Cdk5 Inhibition of Amphiphysin
binding [125]
Angiotensin II type 1 receptor Src [143]
β2-AR, prostacyclin receptor PKA switch coupling from Gs to Gi [16, 17]
GPCRs [Ser/Thr] clusters GRKs Desensitization,recruitment of
arrestins [26]
AP-2 [μ(YxxΦ)] AAK1 TfR endocytosis [144]
AP-2 [μ(YxxΦ)] AAK1 α1a AR endocytosis [145]
AP-2 AAK1 binding to endocytic cargo [83, 84]
AP-2 [μ]G A K [ 85, 86]
AP-2 [α] CK2 Inhibition of clathrin binding [74, 77]
AP-2 [β] CK2 Inhibition of clathrin binding [74, 77]
AP-2 [β] [Tyr-737] c-Src Inhibition of arrestin binding [105]
GRK2 PKC Increase GRK activity [36, 38]
GRK5 PKC Decrease GRK activity [39]
GRK2 c-Src targets GRK2 for degradation [40, 41]
β-arrestin 1 [Ser-412] ERK1,2 Reduce binding to Src and
clathrin [60, 61]
β-arrestin 1 [Ser-412] GRK5 Block Src activation [63]
β-arrestin 1 [Tyr-54] Src Decrease the interaction with the
μ-adaptin [72]
β-arrestin 2 [Thr-383, Ser-361] casein kinase
II
interaction with unidentiﬁed
binding partners [64, 65]
Arr2 CaMKII Unknown [66]
Clathrin heavy chain Src Facilitates membrane binding [78]
Clathrin Light chain CK2 Unknown [75]




Amphiphysin [Ser-261, 272, 276,
285 and Thr-310] Cdk5 Inhibits interaction with the
beta-subunit of AP-2 [125]
Amphiphysin MAPK/ERK Inhibits interaction with AP-2 [135]
Synaptojanin PKC Inhibits interaction with binding
partners [123, 127]
Synaptotagmin CaMKII Probably inhibitory [87]
Epsin Unknown Inhibits interaction with binding
partners [147]
Eps15 Unknown Inhibits interaction with AP-2 [147]
and dynamin I inhibits synaptic vesicle endocytosis through
inhibition of the association of these proteins with their
partner proteins such as β-adaptin [125]. Therefore, it
is possible that the phosphorylation directly regulates the
intramolecular interaction in amphiphysin, which in turn
regulates the interaction with dynamin.
8.2. Amphiphysin Phosphorylation by Mitogen-Activated Pro-
tein Kinase/Extra-Cellular-Signal-Regulated Kinase (MAPK/
ERK). As a second kinase, mitogen-activated protein kinase/
extra-cellular-signal-regulated kinase has been shown to
phosphorylate Amphiphysin I at two sites, also within the
proline/arginine rich domain (PRD) but distinct from those
for cdk5. MAPK/ERK phosphorylates amphiphysin I at Ser-
285 and Ser-293. This phosphorylation negatively regulates
the amphiphysin binding to AP-2 [135].
8.3. Amphiphysin Phosphorylation by CK2. Phosphorylation
of amphiphysin-1 can regulate its interaction with the
heavy chain of clathrin. This interaction is mediated by
two clathrin binding motifs of amphiphysin, the clathrin
box and the W box. Two threonine residues, conserved in
amphiphysin-1 and -2, are among several vertebrate species
that can be phosphorylated by CK2. The phosphorylation8 International Journal of Cell Biology
of Thr-350 and Thr-387 in amphiphysin by CK2 regulates
the interaction of amphiphysin and clathrin [136].
9.DifferentRolesofProteinsPhosphorylation
Coated vesicle formation is a constitutive process that
involves continuous cycling of the coat proteins from the
cytosol onto the membrane. Reversible phosphorylation is,
therefore, a plausible mechanism for how this might be
regulated. Phosphorylation events can be classiﬁed into two
functionally opposite classes: (i) those that are inhibitory for
CCV formation and (ii) those that facilitate the assembly of
CCVs.
Fewexamplesofphosphorylation mechanisms occurring
during GPCRs internalization were previously reported
(see Table 1). Indeed, dynamin was shown to be tyrosine
phosphorylated and to regulate β2-AR internalization [100].
Interestingly, Fessart et al. found that activation of AT1R
promotes the tyrosine phosphorylation of the β2-subunit of
AP-2, to regulate its interaction with β-arrestin [101, 105].
Probably another best characterized example is phosphory-
lation in the hinge region of the α-a n dβ2-subunits of the
AP-2 complex. Phosphorylated AP-2 has a reduced ability
to interact with clathrin and requires dephosphorylation for
eﬃcient interaction [74, 77]. Phosphorylation also appears
to be important in modulating the function of several other
proteins implicated in endocytosis; these includedynamin 1,
clathrin, amphiphysins 1 and 2, AP-180, synaptojanin, epsin
and Eps15. These proteins are found to be phosphorylated
in resting nerve terminals and dephosphorylated when
stimulation invokes a burst of CCV formation [123]. It was
shown that phosphorylation of dynamin 1 and synaptojanin
1 inhibits their binding to amphiphysin, while phosphory-
lated amphiphysin has an impaired aﬃnity for AP-2 and
clathrin [127]. For example, in vitro dephosphorylation
of rat brain extracts apparently promotes the assembly of
dynamin I, synaptojanin, amphiphysin, clathrin, and AP-2
into complexes [127].
The other angle of the story that would be particularly
interestingistheinvivorolesofdissociation. Inotherswords,
how and why these endocytic complexes dissociate? Close
examination of AP-1 [137]a n dβ-arrestin [65] shows that an
eﬀective way of regulating compartmental speciﬁcity could
be dephosphorylation or phosphorylation by phosphatases
and kinases restricted to deﬁned membrane regions. These
focal posttranslational modiﬁcations could modulate the
avidity between network members, promoting assembly
(and disassembly) of sorting lattices only at the appropriate
location and time. For example, it has been reported that
Ark1p (standing for actin regulating kinase 1)/Prk1p (stand-
ing for p53 regulating kinase 1)-mediated phosphorylation
of a S. cerevisiae endocytic, eps15-like accessory factor
governs the post budding inactivation of Arp2/3-dependent
actinpolymerization,preparingthetransport vesicleforsub-
sequent fusion [138]. The role of protein phosphorylation
in controlling clathrin-coated vesicle formation at the cell
surface remains relatively unexplored.
Another explanation is that phosphorylation could also
promote the recruitment of new interacting proteins with a
SH2 domain. Nevertheless, proof of this model will require
crystallization of the phosphorylated endocytic complexes.
For example, since the crystal structure was obtained for
β2-adaptin [139], it will be important in future studies
to examine the crystal structure of wild-type β2-adaptin
as compared to phosphorylated β2-adaptin. A structural
approach will be useful in demonstrating the ability of phos-
phorylated β2-adaptin to bind, or not, endocytic proteins.
It is not unlikely that a protein with an SH2 domain would
make an excellent binding partner for c-Src phosphorylated
tyrosine residue within β2-adaptin. Other AP-2 subunits
when phosphorylated increase their aﬃnity for diﬀerent
proteins. The aﬃnity of phosphorylated μ2 for peptides
containing the tyrosine-containing internalization motif in
the cytoplasmic tails of receptors has been shown to be
much greater that of unphosphorylate μ2. Recent structural
data on AP-2 suggest a possible molecular explanation for
these observations. Apparently, the binding site in μ2f o rt h e
tyrosine-containing motif is buried in the AP-2 complex,
thus a conformational change is required for its exposure.
This could be triggered by phosphorylation of μ2[ 140]. In
parallel, to verify and identify new proteins interacting with
phosphorylated endocytic proteins, a proteomic approach
would inform us on the partner(s) recruited during GPCRs
endocytosis.
Howendocyticphosphorylation cyclesareregulatedisan
important questionfor the future. Further studies onregula-
tory inputs and control mechanisms will provide important
insight into the events controlling receptor endocytosis.
10. FuturesProspectsin Phosphorylation
and Internalization
While the mechanisms involved in regulating the clathrin-
mediated endocytic pathway are not fully understood,
accumulating evidence suggests that phosphorylation cycles
may be a key step [127, 141]. Indeed, phosphorylation of
the clathrin heavy chain [78] and the large and medium
subunits of AP-2 [74, 142] have been demonstrated to
be important to the clathrin-mediated internalization of
growth factors and nutrients, respectively. However, the
phosphorylation of endocytic factors is not limited to the
major coat components. Many others constituents of the
endocytic machinery including dynamin1, amphiphysin 1
and 2, synaptojanin, AP180, epsin and eps15, and AP-2 are
phosphorylated. Although it is clear that phosphorylation
plays an important role in clathrin-mediated internalization,
a more detailed understanding of the endocytic regulatory
mechanisms will require the identiﬁcation of the respective
k i n a s e st h a tt a r g e te n d o c y t i cc o m p o n e n t s .M u l t i p l ek i n a s e s
of clathrin-coated vesicles have been deﬁned, for example
AAK1phosphorylates theμ2 subunitofAP-2 [84],Srckinase
phosphorylates clathrin [78], and the β2-subunit of AP-2
[105]. Previous observations suggest that the poly-L-lysine
dependent phosphorylation of AP-2 preventsits recruitment
to clathrin cages [74]. Thus, it is reasonable to believe thatInternational Journal of Cell Biology 9
phosphorylation may regulate the ability of AP-2 to interact
with other endocytic proteins, such as β-arrestin. However,
we can not exclude the fact that phosphorylation may also
inﬂuenceAP-2localization.Previousstudieshaveestablished
thatβ2-adaptin isphosphorylated invivobyastaurosporine-
sensitive kinase whose function is balanced by the con-
stitutive activity of protein phosphatase 2A (PP2A) [142].
They also observed that treatment of cells with agents that
blockPP2A function perturb AP-2 localization at the plasma
membrane and disrupt transferrin internalization. Thus, as
suggested by Slepnev et al. [127], it is possible that one
potential mechanism to regulate the cycles of coat protein
assembly and disassembly is reversible phosphorylation.
In conclusion, phosphorylation appears to be an impor-
tant mechanism by which GPCRs regulate their own inter-
nalization. We currently have only a few pieces of the puzzle
available. The identity of many kinases and phosphatases,
their location, and the timing of their action remain to be
determined. In the future, it will be interesting to investigate
the molecular consequences of protein phosphorylation,
how kinases are regulated, and where and how phospho-
rylation versus dephosphorylation occurs. These issues are
crucial to our understanding for the regulation of receptor
internalization through clathrin-coated vesicles
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